LPL Financial’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$107M Buy
3,723,288
+1,473,591
+66% +$42.9M 0.03% 547
2025
Q4
$63.6M Buy
2,249,697
+443,608
+25% +$12.5M 0.02% 754
2025
Q3
$50.5M Sell
1,806,089
-66,877
-4% -$1.82M 0.01% 845
2025
Q2
$49.2M Buy
1,872,966
+117,958
+7% +$2.93M 0.02% 770
2025
Q1
$44.3M Buy
1,755,008
+98,489
+6% +$2.51M 0.02% 736
2024
Q4
$41M Sell
1,656,519
-98,906
-6% -$2.56M 0.02% 754
2024
Q3
$44.6M Buy
1,755,425
+297,591
+20% +$7.23M 0.02% 670
2024
Q2
$34M Buy
1,457,834
+561,650
+63% +$13.1M 0.02% 726
2024
Q1
$21.5M Buy
896,184
+705,538
+370% +$15.8M 0.01% 918
2023
Q4
$4.13M Buy
190,646
+112,551
+144% +$2.32M ﹤0.01% 1815
2023
Q3
$1.59M Buy
+78,095
New +$1.65M ﹤0.01% 2499

Other funds holding REVS

LPL Financial's REVS Position: Q1 2026 in Review

LPL Financial increased its Columbia Research Enhanced Value ETF (REVS) stake by 66% in Q1 2026, buying an estimated $42.9M and bringing the position to 3,723,288 shares worth $107M. The position accounts for 0.03% of the portfolio, ranked #547.

LPL Financial first reported a position in REVS in Q3 2023 and has held it in 11 quarters since. 37 funds tracked by Wall St. Rank hold REVS as of Q1 2026.

  • LPL Financial held 3,723,288 shares of Columbia Research Enhanced Value ETF worth $107M as of Q1 2026.
  • LPL Financial bought 1,473,591 Columbia Research Enhanced Value ETF shares in Q1 2026, an estimated $42.9M.
  • Columbia Research Enhanced Value ETF made up 0.03% of LPL Financial's portfolio in Q1 2026, its #547 holding.
  • LPL Financial first reported a position in Columbia Research Enhanced Value ETF in Q3 2023 and has held it in 11 quarters since.
  • 37 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.